Exposed: NIH Owns Patent for Controversial COVID-19 Vaccine

New documents obtained by Axios and Public Citizen suggest that the National Institute of Health (NIH) owns half the key patent for Moderna’s controversial COVID vaccine and could collect half the royalties. In addition, four NIH scientists have filed their own provisional patent application as co-inventors. Little known NIH regulations let agency scientists collect up to $150,000.00 annually in royalties from vaccines upon … Continue reading Exposed: NIH Owns Patent for Controversial COVID-19 Vaccine